Capabilities of 99mTc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillation

AIM. To estimate the capabilities of 99mTc-pyrphotech single-photon emission computed tomography (SPECT) in the diagnosis of myocardial inflammatory changes in patients with persistent atrial fibrillation (AF). MATERIALS AND METHODS. Nineteen patients (11 males and 8 females, mean age 47.46±9.92 yea...

Full description

Bibliographic Details
Main Authors: S I Sazonova, Iu B Lishmanov, R E Batalov, S V Popov, Iu N Il'iushenkova, Iu V Rogovskaia, M Z Idrisov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2014-12-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31577
id doaj-7dd4742b89dd43e3bae1c8b6ae8793b8
record_format Article
spelling doaj-7dd4742b89dd43e3bae1c8b6ae8793b82020-11-25T03:32:54Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422014-12-018612101428593Capabilities of 99mTc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillationS I SazonovaIu B LishmanovR E BatalovS V PopovIu N Il'iushenkovaIu V RogovskaiaM Z IdrisovAIM. To estimate the capabilities of 99mTc-pyrphotech single-photon emission computed tomography (SPECT) in the diagnosis of myocardial inflammatory changes in patients with persistent atrial fibrillation (AF). MATERIALS AND METHODS. Nineteen patients (11 males and 8 females, mean age 47.46±9.92 years) with persistent idiopathic AF underwent preoperative complete clinical and instrumental examination. 99mTc-pyrphotech SPECT was performed to identify foci of myocardial inflammatory changes. After completing 99mTC-pyrphotech scanning, resting myocardial perfusion scintigraphy with 99mTC-methoxyisobutylisonitrile (99mTc-MIBI) was performed in accordance with the standard protocol. The scintigrams obtained in both studies were then combined using the applied programs Jet Stream Workspace Release 2.5 (Philips) and the application Fusion. During invasive intervention, endomyocardial samples were intraoperatively taken from all the patients for histological and immunohistochemical examinations. RESULTS. Abnormal 99mTc-pyrphotech myocardial accumulation was found in 7 (36.8%) of the examinees, multiple foci in 3 cases and single foci in 4. Analysis of perfusion scintigrams indicated that the mean abnormal accumulation of 99mTc-MIBI in the left ventricle was 3.75±0.88% (maximum 9%).Histological examination of endomyocardial samples from 19 patients with persistent AF verified myocarditis in 4 (21%) patients and myocardial sclerosis concurrent with other abnormalities in 15 (78.9%) patients. CONCLUSION. Latent lymphocytic or polymorphic cellular myocarditis of viral etiology is a cause of idiopathic AF in 20% of the cases. 99mTc-pyrphotech scintigraphy may be one of the primary noninvasive diagnostic techniques for the detection of myocardial inflammation in this form of arrhythmia.https://ter-arkhiv.ru/0040-3660/article/view/31577myocarditismyocardial scintigraphyatrial fibrillation
collection DOAJ
language Russian
format Article
sources DOAJ
author S I Sazonova
Iu B Lishmanov
R E Batalov
S V Popov
Iu N Il'iushenkova
Iu V Rogovskaia
M Z Idrisov
spellingShingle S I Sazonova
Iu B Lishmanov
R E Batalov
S V Popov
Iu N Il'iushenkova
Iu V Rogovskaia
M Z Idrisov
Capabilities of 99mTc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillation
Терапевтический архив
myocarditis
myocardial scintigraphy
atrial fibrillation
author_facet S I Sazonova
Iu B Lishmanov
R E Batalov
S V Popov
Iu N Il'iushenkova
Iu V Rogovskaia
M Z Idrisov
author_sort S I Sazonova
title Capabilities of 99mTc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillation
title_short Capabilities of 99mTc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillation
title_full Capabilities of 99mTc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillation
title_fullStr Capabilities of 99mTc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillation
title_full_unstemmed Capabilities of 99mTc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillation
title_sort capabilities of 99mtc-pyrphotech single-photon emission computed tomography in combination with myocardial perfusion scintigraphy in the evaluation of inflammatory changes in the heart of patients with persistent atrial fibrillation
publisher "Consilium Medicum" Publishing house
series Терапевтический архив
issn 0040-3660
2309-5342
publishDate 2014-12-01
description AIM. To estimate the capabilities of 99mTc-pyrphotech single-photon emission computed tomography (SPECT) in the diagnosis of myocardial inflammatory changes in patients with persistent atrial fibrillation (AF). MATERIALS AND METHODS. Nineteen patients (11 males and 8 females, mean age 47.46±9.92 years) with persistent idiopathic AF underwent preoperative complete clinical and instrumental examination. 99mTc-pyrphotech SPECT was performed to identify foci of myocardial inflammatory changes. After completing 99mTC-pyrphotech scanning, resting myocardial perfusion scintigraphy with 99mTC-methoxyisobutylisonitrile (99mTc-MIBI) was performed in accordance with the standard protocol. The scintigrams obtained in both studies were then combined using the applied programs Jet Stream Workspace Release 2.5 (Philips) and the application Fusion. During invasive intervention, endomyocardial samples were intraoperatively taken from all the patients for histological and immunohistochemical examinations. RESULTS. Abnormal 99mTc-pyrphotech myocardial accumulation was found in 7 (36.8%) of the examinees, multiple foci in 3 cases and single foci in 4. Analysis of perfusion scintigrams indicated that the mean abnormal accumulation of 99mTc-MIBI in the left ventricle was 3.75±0.88% (maximum 9%).Histological examination of endomyocardial samples from 19 patients with persistent AF verified myocarditis in 4 (21%) patients and myocardial sclerosis concurrent with other abnormalities in 15 (78.9%) patients. CONCLUSION. Latent lymphocytic or polymorphic cellular myocarditis of viral etiology is a cause of idiopathic AF in 20% of the cases. 99mTc-pyrphotech scintigraphy may be one of the primary noninvasive diagnostic techniques for the detection of myocardial inflammation in this form of arrhythmia.
topic myocarditis
myocardial scintigraphy
atrial fibrillation
url https://ter-arkhiv.ru/0040-3660/article/view/31577
work_keys_str_mv AT sisazonova capabilitiesof99mtcpyrphotechsinglephotonemissioncomputedtomographyincombinationwithmyocardialperfusionscintigraphyintheevaluationofinflammatorychangesintheheartofpatientswithpersistentatrialfibrillation
AT iublishmanov capabilitiesof99mtcpyrphotechsinglephotonemissioncomputedtomographyincombinationwithmyocardialperfusionscintigraphyintheevaluationofinflammatorychangesintheheartofpatientswithpersistentatrialfibrillation
AT rebatalov capabilitiesof99mtcpyrphotechsinglephotonemissioncomputedtomographyincombinationwithmyocardialperfusionscintigraphyintheevaluationofinflammatorychangesintheheartofpatientswithpersistentatrialfibrillation
AT svpopov capabilitiesof99mtcpyrphotechsinglephotonemissioncomputedtomographyincombinationwithmyocardialperfusionscintigraphyintheevaluationofinflammatorychangesintheheartofpatientswithpersistentatrialfibrillation
AT iuniliushenkova capabilitiesof99mtcpyrphotechsinglephotonemissioncomputedtomographyincombinationwithmyocardialperfusionscintigraphyintheevaluationofinflammatorychangesintheheartofpatientswithpersistentatrialfibrillation
AT iuvrogovskaia capabilitiesof99mtcpyrphotechsinglephotonemissioncomputedtomographyincombinationwithmyocardialperfusionscintigraphyintheevaluationofinflammatorychangesintheheartofpatientswithpersistentatrialfibrillation
AT mzidrisov capabilitiesof99mtcpyrphotechsinglephotonemissioncomputedtomographyincombinationwithmyocardialperfusionscintigraphyintheevaluationofinflammatorychangesintheheartofpatientswithpersistentatrialfibrillation
_version_ 1724566043187216384